SNX
TD SYNNEX Corporation NYSE$227.84
Pre-mkt
$227.21
-0.28%
Mkt Cap $18.4B
52w Low $112.27
96.8% of range
52w High $231.62
50d MA $181.00
200d MA $159.77
P/E (TTM)
22.6x
EV/EBITDA
8.0x
P/B
2.2x
Debt/Equity
0.6x
ROE
11.2%
P/FCF
9.0x
RSI (14)
—
ATR (14)
—
Beta
1.23
50d MA
$181.00
200d MA
$159.77
Avg Volume
764.4K
About
TD SYNNEX Corporation provides business process services in the United States and internationally. The company distributes PC systems, mobile phones and accessories, printers, peripherals, supplies, endpoint technology software, consumer electronics, information technology (IT) systems including data center server and storage solutions, system components, software, networking, communications and s…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | AMC | 3.29 | 4.73 | +43.8% | 168.71 | +1.5% | +10.4% | +10.8% | +14.5% | +15.9% | +18.7% | +35.2% | — |
| Jan 8, 2026 | AMC | 3.68 | 3.83 | +4.1% | 147.60 | +1.3% | +1.9% | +1.8% | +5.7% | +1.7% | +1.9% | +16.7% | — |
| Sep 25, 2025 | AMC | 3.05 | 3.58 | +17.4% | 159.69 | +1.9% | +3.0% | +4.0% | +2.5% | +2.9% | +2.7% | -2.9% | — |
| Jun 24, 2025 | AMC | 2.71 | 2.99 | +10.3% | 136.88 | +0.6% | +0.7% | +0.1% | -1.5% | -0.9% | -0.8% | +6.6% | — |
| Mar 27, 2025 | AMC | 2.91 | 2.80 | -3.8% | 107.54 | -0.2% | -2.7% | -3.3% | -3.4% | -0.7% | -7.5% | +3.0% | — |
| Jan 10, 2025 | AMC | 3.07 | 3.09 | +0.7% | 134.01 | -0.8% | -0.9% | +1.5% | +1.7% | +2.4% | +2.3% | +7.0% | — |
| Sep 26, 2024 | AMC | 2.80 | 2.86 | +2.1% | 118.71 | +0.9% | +0.8% | +1.2% | -1.8% | -1.8% | -2.8% | +2.8% | — |
| Jun 25, 2024 | AMC | 2.82 | 2.73 | -3.2% | 116.96 | +0.0% | -0.7% | -1.2% | -1.3% | -2.5% | -3.9% | -0.7% | — |
| Mar 26, 2024 | AMC | 2.84 | 2.99 | +5.3% | 112.27 | +1.4% | +3.3% | +0.7% | +0.4% | +3.7% | +5.3% | +4.6% | — |
| Jan 9, 2024 | AMC | 2.69 | 3.13 | +16.4% | 105.20 | +0.0% | +0.3% | -0.8% | -1.4% | -1.5% | -1.4% | -4.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | RBC Capital | Maintains | Outperform → Outperform | — | $224.04 | $227.40 | +1.5% | +1.8% | +1.9% | — | — | — |
| Apr 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $215.19 | $223.21 | +3.7% | +3.8% | +3.6% | +5.8% | +4.9% | +3.8% |
| Apr 16 | JP Morgan | Maintains | Neutral → Neutral | — | $205.45 | $205.74 | +0.1% | +1.6% | +4.3% | +6.1% | +4.7% | +8.7% |
| Apr 2 | Goldman Sachs | Maintains | Buy → Buy | — | $186.29 | $182.25 | -2.2% | +0.3% | +3.7% | +5.0% | +7.5% | +7.1% |
| Apr 1 | Barrington Research | Maintains | Outperform → Outperform | — | $168.71 | $171.19 | +1.5% | +10.4% | +10.8% | +14.5% | +15.9% | +18.7% |
| Apr 1 | JP Morgan | Maintains | Neutral → Neutral | — | $168.71 | $171.19 | +1.5% | +10.4% | +10.8% | +14.5% | +15.9% | +18.7% |
| Apr 1 | RBC Capital | Maintains | Outperform → Outperform | — | $168.71 | $171.19 | +1.5% | +10.4% | +10.8% | +14.5% | +15.9% | +18.7% |
| Apr 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $168.71 | $171.19 | +1.5% | +10.4% | +10.8% | +14.5% | +15.9% | +18.7% |
| Mar 27 | Barrington Research | Maintains | Outperform → Outperform | — | $159.64 | $158.25 | -0.9% | -1.6% | +0.3% | +5.7% | +16.7% | +17.1% |
| Mar 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $155.33 | $154.30 | -0.7% | -1.6% | +0.7% | +5.3% | +5.4% | +2.8% |
Recent Filings
8-K
Unknown — 8-K Filing
YNNEX's 18.1% revenue growth significantly exceeding guidance suggests strong operational momentum and market demand, likely supporting higher earnings estimates and stock valuation multiples going forward.
Mar 31
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
SYNNEX amended its charter and bylaws, likely adjusting governance structure or shareholder rights; investors should review the exhibits to assess if changes materially affect voting power, board composition, or corporate flexibility.
Mar 27
8-K
Trulieve Cannabis Corp. -- 8-K Filing
Trulieve Cannabis granted its executive immediate vesting of equity awards upon termination, with performance-based awards vesting only upon certification of achieved performance goals.
Mar 5
Data updated apr 27, 2026 2:16am
· Source: massive.com